共 19 条
- [15] Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 8 (07)
- [17] Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects. Enhancement with interleukin-2(IL-2), IL-12, and IL-15 CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 82 (02): : 163 - 173